Your browser doesn't support javascript.
loading
Pericardial fluid of cardiac patients elicits arterial constriction: role of endothelin-1.
Nemeth, Zoltan; Cziraki, Attila; Szabados, Sandor; Horvath, Ivan; Koller, Akos.
Afiliação
  • Nemeth Z; a University of Pecs, Medical School, Department of Pathophysiology and Gerontology and Szentagothai Research Centre, Pecs, Hungary.
  • Cziraki A; b University of Pecs, Medical School, Heart Institute, Pecs, Hungary.
  • Szabados S; b University of Pecs, Medical School, Heart Institute, Pecs, Hungary.
  • Horvath I; b University of Pecs, Medical School, Heart Institute, Pecs, Hungary.
  • Koller A; a University of Pecs, Medical School, Department of Pathophysiology and Gerontology and Szentagothai Research Centre, Pecs, Hungary.
Can J Physiol Pharmacol ; 93(9): 779-85, 2015 Sep.
Article em En | MEDLINE | ID: mdl-26322806
ABSTRACT
Recently, several vasoactive molecules have been found in pericardial fluid (PF). Thus, we hypothesized that in coronary artery disease due to ischemia or ischemia-reperfusion, the level of vasoconstrictors, mainly endothelin-1 (ET-1), increases in PF, which can increase the vasomotor tone of arteries. Experiments were performed using an isometric myograph. Vasomotor effects of PF from patients undergoing coronary artery bypass graft (PFCABG, n = 14) or valve replacement (PFVR, n = 7) surgery were examined in isolated rat carotid arteries (N = 14; n = 26). Vasomotor responses to KCl (40 or 60 mmol/L) were also tested. The selective endothelin A receptor antagonist BQ123 (10(-6) mol/L) was used to elucidate the role of ET-1. Both the first and the second additions of KCl elicited increases in the isometric force of the isolated arteries (KCl1, 6.1 ± 0.2 mN; KCl2, 6.5 ± 0.9 mN). PFCABG and PFVR elicited substantial increases in the isometric force of arteries (PFCABG, 3.1 ± 0.7 mN; PFVR, 3.0 ± 0.9 mN; p > 0.05). The presence of the selective endothelin A receptor blocker significantly reduced arterial contractions to PFCABG (before BQ123, 2.6 ± 0.5 mN vs. after BQ123, 0.8 ± 0.1 mN; p < 0.05). This study is the first to demonstrate that PFs of patients elicit substantial arterial constrictions, which is mediated primarily by ET-1. Interfering with the vasoconstrictor action of PF could be a potential therapeutic target to improve coronary blood flow in cardiac patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasoconstrição / Doença da Artéria Coronariana / Artérias Carótidas / Endotelina-1 / Líquido Pericárdico Limite: Animals / Humans / Male Idioma: En Revista: Can J Physiol Pharmacol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Hungria

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasoconstrição / Doença da Artéria Coronariana / Artérias Carótidas / Endotelina-1 / Líquido Pericárdico Limite: Animals / Humans / Male Idioma: En Revista: Can J Physiol Pharmacol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Hungria